腱生蛋白C通过αvβ6整合素信号损害肾小管完整性促进AKI向CKD进展
本研究探讨腱生蛋白C(TNC)作为肾纤维化生物标志物和介导者的作用。在225例CKD患者中,尿TNC水平较39例健康人显著升高,且与肾功能损害和纤维化严重程度相关。小鼠缺血再灌注AKI-to-CKD模型中,敲除TNC可保留肾小管完整性并减轻纤维化。机制上TNC通过αvβ6整合素/FAK信号诱导部分上皮-间质转化,阻断该通路可改善纤维化。
要点
- 尿TNC是CKD肾纤维化的无创生物标志物,与肾功能和纤维化程度相关
- TNC通过αvβ6整合素/FAK信号诱导肾小管部分上皮-间质转化,损害小管完整性
- 阻断TNC/αvβ6/FAK信号 cascade 可减轻肾纤维化,是潜在治疗靶点
核心结论
- TNC是肾纤维化的无创生物标志物和致病介质,通过损害肾小管完整性促进AKI向CKD进展。
- 阻断TNC/αvβ6整合素/FAK信号 cascade 可能是肾纤维化的新型治疗策略。
研究设计与样本
- 研究纳入225例CKD患者和39例健康个体,检测尿TNC水平并与肾功能和纤维化关联。
- 使用小鼠缺血再灌注诱导的AKI-to-CKD模型,以及体外细胞实验和脱细胞肾脏支架。
主要发现
- CKD患者肾活检中TNC增加,尿TNC水平较健康个体显著升高,且与肾功能损害和纤维化严重程度相关。
- 小鼠模型中敲除TNC可保留肾小管完整性并减轻肾纤维化病变。
- 体外TNC通过诱导部分上皮-间质转化损害肾小管细胞完整性,TNC富集的脱细胞支架促进上皮-间质转化。
- 机制上TNC特异性诱导肾小管细胞αvβ6整合素并激活FAK。
- 阻断αvβ6整合素或抑制FAK可抑制上皮-间质转化、恢复小管完整性并减轻肾纤维化。
临床怎么用
- 尿TNC可作为CKD肾纤维化的无创监测生物标志物。
- 靶向TNC/αvβ6整合素/FAK信号通路可能为肾纤维化提供治疗干预新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tenascin-C is an extracellular matrix glycoprotein that plays a critical role in kidney fibrosis by orchestrating a fibrogenic niche. Here, we demonstrate that tenascin-C is a biomarker and a mediator of kidney fibrogenesis by impairing tubular integrity. Tenascin-C was found to be increased in kidney biopsies from patients with chronic kidney disease (CKD). In a cohort of 225 patients with CKD, the urinary tenascin-C level was markedly elevated, compared to 39 healthy individuals. Moreover, the level of urinary tenascin-C in CKD was correlated with the severity of kidney dysfunction and fibrosis. In mouse model of acute kidney injury-to-CKD induced by ischemia/reperfusion, depletion of tenascin-C preserved tubular integrity and ameliorated renal fibrotic lesions. In vitro, tenascin-C impaired tubular cell integrity by inducing partial epithelial-mesenchymal transition. Using decellularized kidney tissue scaffolds, we found that tenascin-C-enriched scaffolds facilitated tubular epithelial-mesenchymal transition ex vivo. Mechanistically, tenascin-C specifically induced integrins αvβ6 in tubular cells and activated focal adhesion kinase (FAK). Blocking αvβ6 integrins or inhibition of FAK restored tubular integrity by repressing epithelial-mesenchymal transition and alleviated kidney fibrosis. Thus, our studies underscore that tenascin-C is a noninvasive biomarker of kidney fibrogenesis and a pathogenic mediator that impairs tubular integrity. Hence, blockade of the tenascin-C/αvβ6 integrin/FAK signal cascade may be a novel strategy for therapeutic intervention of kidney fibrosis.
引用
- Zhu H, Liao J, Zhou X, et al. Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney Int. 2020. PMID: 32245660. doi:10.1016/j.kint.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。